| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACC.2011.03.064 |
| P698 | PubMed publication ID | 21903062 |
| P50 | author | Raad Mohiaddin | Q21592535 |
| Dudley Pennell | Q42778112 | ||
| Marc R Dweck | Q57009695 | ||
| Mary N Sheppard | Q61192477 | ||
| Emiliano Angeloni | Q61727769 | ||
| Sanjay Prasad Gupta | Q88466221 | ||
| David E Newby | Q94451652 | ||
| Philip J Kilner | Q114399767 | ||
| Ankur Gulati | Q114399803 | ||
| Andrew Jabbour | Q114438582 | ||
| Timothy Murigu | Q116782014 | ||
| Francisco Alpendurada | Q116782015 | ||
| Isabelle Roussin | Q116782016 | ||
| P2093 | author name string | Stuart A Cook | |
| Giovanni Melina | |||
| Winston Banya | |||
| John Pepper | |||
| Cesare Quarto | |||
| Rick Wage | |||
| Sadaf Raza | |||
| Simone Refice | |||
| Sanjiv Joshi | |||
| Nishant A Prasad | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | stenosis | Q2343082 |
| P304 | page(s) | 1271-1279 | |
| P577 | publication date | 2011-09-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis | |
| P478 | volume | 58 |
| Q33166375 | A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis |
| Q94474448 | A new non-invasive index for prognosis evaluation in patients with aortic stenosis |
| Q35861592 | A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial). |
| Q38996474 | Advanced imaging in valvular heart disease |
| Q38304851 | Advances in cardiac magnetic resonance imaging of congenital heart disease |
| Q26744203 | Aortic Stenosis, a Left Ventricular Disease: Insights from Advanced Imaging |
| Q57044478 | Aortic valvular imaging with cardiovascular magnetic resonance: seeking for comprehensiveness |
| Q53337641 | Assessment of Aortic Valve Disease: Role of Imaging Modalities. |
| Q43931913 | Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. |
| Q42517300 | Assessment of reverse remodeling predicted by myocardial deformation on tissue tracking in patients with severe aortic stenosis: a cardiovascular magnetic resonance imaging study. |
| Q37105484 | Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement: a cardiovascular magnetic resonance study |
| Q61307573 | CMR quantitation of change in mitral regurgitation following transcatheter aortic valve replacement (TAVR): impact on left ventricular reverse remodeling and outcome |
| Q89216879 | Calcific aortic stenosis |
| Q47340269 | Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis |
| Q39392998 | Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease |
| Q47169243 | Cardiovascular magnetic resonance in the evaluation of heart valve disease. |
| Q26767019 | Cardiovascular magnetic resonance: Diagnostic utility and specific considerations in the pediatric population. |
| Q27027825 | Care of patients with apparently asymptomatic severe aortic valve stenosis |
| Q89775559 | Challenges in Aortic Valve Stenosis: Low-Flow States Diagnosis, Management, and a Review of the Current Literature |
| Q52676228 | Clinical applications of multiparametric CMR in left ventricular hypertrophy. |
| Q38958856 | Comparison of exercise testing and CMR measured myocardial perfusion reserve for predicting outcome in asymptomatic aortic stenosis: the PRognostic Importance of MIcrovascular Dysfunction in Aortic Stenosis (PRIMID AS) Study |
| Q28066080 | Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease |
| Q92643229 | Coronary Microcirculation in Aortic Stenosis |
| Q30435363 | Current management of calcific aortic stenosis |
| Q57823261 | Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonance |
| Q38685644 | Diagnosis and management of aortic valve stenosis in patients with heart failure |
| Q26765161 | Diagnosis and management of patients with asymptomatic severe aortic stenosis |
| Q30463822 | Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies |
| Q36262551 | Differences in Aortic Valve and Left Ventricular Parameters Related to the Severity of Myocardial Fibrosis in Patients with Severe Aortic Valve Stenosis |
| Q37380513 | Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis. |
| Q37153614 | Early detection of subclinical ventricular deterioration in aortic stenosis with cardiovascular magnetic resonance and echocardiography. |
| Q34196043 | Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations |
| Q33894813 | Effects of Aortic Valve Replacement on Severe Aortic Stenosis and Preserved Systolic Function: Systematic Review and Network Meta-analysis |
| Q36360615 | Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis |
| Q36634469 | Evaluation of Aortic Blood Flow and Wall Shear Stress in Aortic Stenosis and Its Association With Left Ventricular Remodeling |
| Q33166086 | Evaluation of Tp-E Interval and Tp-E/QT Ratio in Patients with Aortic Stenosis. |
| Q38205777 | Exploring the biology of valvular heart disease: Time to move into the twenty-first century |
| Q35945674 | Extracellular volume quantification in isolated hypertension - changes at the detectable limits? |
| Q35064751 | Futility, benefit, and transcatheter aortic valve replacement |
| Q41200048 | Genetic Ablation of Fgf23 or Klotho Does not Modulate Experimental Heart Hypertrophy Induced by Pressure Overload. |
| Q30446792 | Heart failure in patients with normal coronary anatomy: diagnostic algorithm and disease pattern of various etiologies as defined by cardiac MRI. |
| Q47119301 | Heart failure: a story of damage, fatigue and injury? |
| Q37977134 | Heart valve disease: investigation by cardiovascular magnetic resonance |
| Q34145900 | High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis |
| Q92465980 | Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis |
| Q36220925 | Histologic validation of myocardial fibrosis measured by T1 mapping: a systematic review and meta-analysis |
| Q36939654 | Human non-contrast T1 values and correlation with histology in diffuse fibrosis |
| Q38045578 | Hypertrophic reprogramming of the left ventricle: translation to the ECG |
| Q53107354 | Identification of myocardial diffuse fibrosis by 11 heartbeat MOLLI T 1 mapping: averaging to improve precision and correlation with collagen volume fraction. |
| Q61804313 | Imaging and Impact of Myocardial Fibrosis in Aortic Stenosis |
| Q46986760 | Imaging technique and current status of valvular heart disease using cardiac MRI |
| Q89475098 | Impact of left ventricular remodelling patterns on outcomes in patients with aortic stenosis |
| Q89675772 | Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis |
| Q50027307 | Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study. |
| Q61847089 | Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP. |
| Q64245084 | Incremental Predictive Value of Longitudinal Axis Strain and Late Gadolinium Enhancement Using Standard CMR Imaging in Patients with Aortic Stenosis |
| Q35534909 | Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload |
| Q91012169 | Late Gadolinium Enhancement Predicts Improvement in Global Longitudinal Strain after Aortic Valve Replacement in Aortic Stenosis |
| Q36051837 | Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement |
| Q91738643 | Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement |
| Q36278641 | Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance |
| Q39555199 | Lipoprotein(a) in patients with aortic stenosis: Insights from cardiovascular magnetic resonance |
| Q26824231 | Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies |
| Q57721014 | Magnetic resonance imaging: Physics basics for the cardiologist |
| Q36428548 | Mechanical effects of left ventricular midwall fibrosis in non-ischemic cardiomyopathy. |
| Q30375735 | Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study |
| Q98568569 | MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3β |
| Q37279267 | Mid wall fibrosis on CMR with late gadolinium enhancement may predict prognosis for LVAD and transplantation risk in patients with newly diagnosed dilated cardiomyopathy-preliminary observations from a high-volume transplant centre |
| Q92155367 | Missing Link between Molecular Aspects of Ventricular Arrhythmias and QRS Complex Morphology in Left Ventricular Hypertrophy |
| Q90719850 | Multimodality Imaging for the Assessment of Severe Aortic Stenosis |
| Q26765507 | Multimodality imaging in heart valve disease |
| Q38211896 | Multimodality imaging of heart valve disease |
| Q47096657 | Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis |
| Q57720988 | Myocardial Scar and Mortality in Severe Aortic Stenosis |
| Q35174325 | Myocardial T1 mapping: techniques and potential applications |
| Q26996570 | Myocardial Tissue Characterization: Histological and Pathophysiological Correlation |
| Q36931178 | Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions |
| Q64071068 | Myocardial fibrosis by late gadolinium enhancement cardiovascular magnetic resonance in myotonic muscular dystrophy type 1: highly prevalent but not associated with surface conduction abnormality |
| Q35952919 | Native Magnetic Resonance T1-Mapping Identifies Diffuse Myocardial Injury in Hypothyroidism |
| Q58702276 | Newer echocardiographic techniques for aortic-valve imaging: Clinical aids today, clinical practice tomorrow |
| Q34808068 | Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy |
| Q37691774 | Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis |
| Q59126305 | Osteoprotegerin and Myocardial Fibrosis in Patients with Aortic Stenosis |
| Q37241166 | Pathological ventricular remodeling: mechanisms: part 1 of 2 |
| Q29994666 | Patient selection for transcatheter aortic valve replacement: A combined clinical and multimodality imaging approach |
| Q38492359 | Patterns of left ventricular remodeling in aortic stenosis: therapeutic implications |
| Q58719773 | Predicting Disease Progression and Mortality in Aortic Stenosis: A Systematic Review of Imaging Biomarkers and Meta-Analysis |
| Q37497985 | Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function |
| Q49646856 | Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis |
| Q36256066 | Prevalence, Patterns, and Clinical Predictors of Left Ventricular Late Gadolinium Enhancement in Patients Undergoing Cardiac Magnetic Resonance Prior to Pulmonary Vein Antral Isolation for Atrial Fibrillation: A Cross-Sectional Observational Study |
| Q38663699 | Prognostic Impact of Peak Aortic Jet Velocity in Conservatively Managed Patients With Severe Aortic Stenosis: An Observation From the CURRENT AS Registry |
| Q35751037 | Prognostic Impact of Tricuspid Regurgitation in Patients Undergoing Aortic Valve Surgery for Aortic Stenosis |
| Q36136687 | Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement. |
| Q57281832 | Prognostic value of pre-procedural left ventricular strain for clinical events after transcatheter aortic valve implantation |
| Q55661595 | Progression of Hypertrophy and Myocardial Fibrosis in Aortic Stenosis: A Multicenter Cardiac Magnetic Resonance Study. |
| Q37448642 | Rationale and design of the PRognostic Importance of MIcrovascular Dysfunction in asymptomatic patients with Aortic Stenosis (PRIMID-AS): a multicentre observational study with blinded investigations |
| Q36133677 | Real-time magnetic resonance imaging guidance improves the diagnostic yield of endomyocardial biopsy |
| Q48024326 | Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients. |
| Q36287921 | Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis |
| Q95825238 | Response to Crozatier and Ventura-Clapier |
| Q51748741 | Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis. |
| Q26801333 | Risk Stratification in Patients With Aortic Stenosis Using Novel Imaging Approaches |
| Q64101648 | Role of Cardiac Computed Tomography in the Diagnosis of Left Ventricular Myocardial Diseases |
| Q90370389 | Role of advanced left ventricular imaging in adults with aortic stenosis |
| Q90653207 | Severe Asymptomatic Unicuspid Aortic Stenosis, Myocardial Fibrosis, and Sudden Death: Relevance of Multimodality Imaging |
| Q47575590 | Sex Dimorphism in the Myocardial Response to Aortic Stenosis. |
| Q92993352 | Sex differences in left ventricular remodelling, myocardial fibrosis and mortality after aortic valve replacement |
| Q89161608 | Sex-Specific Considerations in Women with Aortic Stenosis and Outcomes After Transcatheter Aortic Valve Replacement |
| Q48266729 | Sudden cardiac death in asymptomatic aortic stenosis: is the valve to blame? |
| Q26744817 | The Role of Imaging in Aortic Valve Disease |
| Q60923154 | The Role of Imaging in Measuring Disease Progression and Assessing Novel Therapies in Aortic Stenosis |
| Q47138562 | The challenge of co-existent moderate aortic stenosis and left ventricular systolic impairment |
| Q37537964 | The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . |
| Q26861081 | The left ventricle in aortic stenosis--imaging assessment and clinical implications |
| Q38068352 | The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies |
| Q26739737 | The role of cardiovascular magnetic resonance in the assessment of severe aortic stenosis and in post-procedural evaluation following transcatheter aortic valve implantation and surgical aortic valve replacement |
| Q97645768 | The use of cardiovascular magnetic resonance for the assessment of left ventricular hypertrophy |
| Q57175247 | Timing of intervention in aortic stenosis: a review of current and future strategies |
| Q27003231 | Tissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imaging |
| Q90236899 | Urea level is an independent predictor of mortality in patients with severe aortic valve stenosis |
| Q30359543 | Utility of magnetic resonance imaging in the evaluation of left ventricular thickening. |
| Q47998899 | Valvular Heart Disease in Women, Differential Remodeling, and Response to New Therapies |
| Q84465140 | [Low flow/low gradient aortic valve stenosis : clinical and diagnostic management] |
| Q85939518 | fQRS as a noninvasive marker for an overgrowing epidemy affecting both aortic valve and myocardium in the era of aging population |
Search more.